Stocktoria
Arcutis Biotherapeutics, Inc. ARQT
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-01-31
Arcutis Biotherapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 8,622,618 | $80.2M |
| D. E. Shaw & Co., Inc. | 2,496,222 | $58.8M |
| Point72 Asset Management, L.P. | 590,877 | $13.9M |
| AQR CAPITAL MANAGEMENT LLC | 468,253 | $11.0M |
| RENAISSANCE TECHNOLOGIES LLC | 440,999 | $10.4M |
| TWO SIGMA INVESTMENTS, LP | 234,307 | $5.5M |
| CITADEL ADVISORS LLC | 98,206 | $2.3M |
| MILLENNIUM MANAGEMENT LLC | 49,333 | $1.2M |
Source: SEC EDGAR filings · CIK 0001787306 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.